Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 14/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30531889 | 0.88 | RORC (0.61) | RORCCA1CA2ALDH1A1GAA | |
| SCHEMBL28352943 | 0.88 | RORC (0.61) | RORCCA1CA2ALDH1A1GAA | |
| SCHEMBL28349854 | 0.87 | CA2 (0.64) | RORCCA1CA2ALDH1A1 | |
| SCHEMBL20015583 | 0.86 | HDAC6 (0.64) | CA1CA2ALDH1A1GAAHSD17B10 | |
| SCHEMBL28348775 | 0.86 | RORC (0.58) | RORCCA1CA2ALDH1A1GAA | |
| SCHEMBL24025161 | 0.85 | HDAC2 (0.56) | CA1CA2ALDH1A1GAAHSD17B10 | |
| SCHEMBL23080259 | 0.85 | HDAC6 (0.56) | CA1CA2ALDH1A1GAAHSD17B10 | |
| SCHEMBL29488705 | 0.84 | RORC (0.71) | RORCCA1CA2ALDH1A1TP53 | |
| SCHEMBL21969929 | 0.82 | HDAC6 (0.56) | CA1CA2ALDH1A1GAAHSD17B10 | |
| SCHEMBL29332482 | 0.82 | TSHR (0.64) | CA1CA2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110724075-A | Amide compound, pharmaceutical composition containing same, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2020-01-24 | — | — | CN | disclosed |